I'm with you PGG. Anybody who sells now might miss a huge payday. I don't blame them for selling. I just believe Bavi has an excellent chance to join the Standard of Care for multiple cancer types. I believe it will prove more effective in more cancers than Avastin with a much better safety profile. Avastin is worth billions. Bavi may be too.
PGG...from what we saw in the Phase II... IMO I expect we'll see the Bavi arm with a MOS of 12-13 months and the Doce arm with a MOS of 5-6 months. There is lots of room for variation when the difference between the two arms could be 100% or more. I sleep well at night. Everyone do your own due diligence and make your decision based on facts...not what someone else says.
News 
Market Data 
Discover 
